Dana-Farber Cancer Institute Harvard University — Boston, Massachusetts

Dana-Farber Cancer Institute Harvard University is a clinical research site located in Boston, Massachusetts, United States.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Institute Harvard University has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Chronic Myeloid Leukemia, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant.

Sponsors: Gruppo Italiano Malattie EMatologiche dell'Adulto, University of California, San Francisco, Washington University School of Medicine.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

• Massachusetts General Hospital Translational and Clinical Research Center
• Boston VA CSP Coordinating Center
• Boston Children's Hospital / Dana Farber Cancer Institute / Massachusetts General Hospital
• Massachusetts General Hospital Site Number : 002
• Laboratories of Cognitive Neuroscience, Boston Children's Hospital
• The Brigham and Women's Hospital Department of Anesthesiology
• Tuft University Hospital
• Boston Children's Hospital /ID# 162863
• Dana Farber Cancer Institute/Children's Hospital of Boston
• Brigham and Women's Hospital
• Brigham & Woman's Hospital/Boston
• Caritus St. Elizabeth's Hospital

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Institute Harvard University?

Dana-Farber Cancer Institute Harvard University has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Institute Harvard University conducted?

Dana-Farber Cancer Institute Harvard University has 4 clinical trials on record, with 1 currently active. Their work covers Chronic Myeloid Leukemia, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant.

Is Dana-Farber Cancer Institute Harvard University accredited by Crixeo Clinical Trials?

Dana-Farber Cancer Institute Harvard University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Cancer Institute Harvard University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.